Background: The objectives of the Drug-related infectious diseases (DRID) network are to share the latest developments on drug-related infectious diseases in Europe and to identify steps needed to improve the production, availability and use of public health-oriented information at the European level. This meeting report provides an overview of the content of the DRID meeting that took place online on 26-27 October 2021, focusing on:

• the direct impact of COVID-19 on people who use drugs and the COVID‑19 vaccination campaign among this group;
• a review of recent HIV trends and outbreaks, as well as infectious endocarditis linked to injecting drug use with a focus on risk factors and control measures in place;
• country experiences in the elimination of viral hepatitis as a public health threat among people who inject drugs (PWID) and related EMCDDA projects, with a focus on harm reduction and the continuum of care.

The DRID network brings together national experts nominated by national focal points of the EU Member States, Norway and Turkey, as well as institutional partners (ECDC, WHO, Correlation). The meeting also welcomed experts from the Western Balkans (IPA7 project), the European Neighbourhood Policy countries (EU4MD project), Georgia, the United Kingdom, Australia and the United States. Participating experts come from ministries of health, public health institutes, drugs agencies, health services, universities, research institutes and civil society.

• COVID-19 and people who use drugs
• Outbreaks of drug-related infectious diseases
• Eliminating viral hepatitis
• Conclusion
• References